Antioxidant action via p53-mediated apoptosis

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1723-1729

  Liu, Ming ^a   Pelling, Jill C ^b   Ju, Jingfang ^c   Chu, Edward ^c   Brash, Douglas E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; DNA; PROPRANOLOL DERIVATIVE; PROTEIN P53; TROLOX C;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; GENE EXPRESSION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BUTHIONINE SULFOXIMINE; CELLS, CULTURED; DIMERCAPROL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; MICE; OXIDATION-REDUCTION; PYRROLIDONECARBOXYLIC ACID; SULFHYDRYL COMPOUNDS; THIAZOLES; THIAZOLIDINES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN E;

EID: 0032522798     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Miquel, J., Quintanilha, A. T., and Weber, H. CRC Handbook of Free Radicals and Antioxidants in Biomedicine, Vol. II. Boca Raton, FL: CRC Press, 1989.
2. Hockenbery, D. M., Oltavai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75: 241-251, 1993.
3. Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., and Tsujimoto, Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (Lond.), 374: 811-813, 1995.
4. Jacobson, M. D., and Raff, M. C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature (Lond.), 374: 814-816, 1995.
5. Tsai, J., Jain, M., Hsieh, C., Lee, W., Yoshizum, M., Patterson, C., Perrella, M., Cooke, C., Wang, H., Haber, E., Schlegel, R., and Lee, M. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J. Biol. Chem., 271: 3667-3670, 1996.
6. Cerutti, P. A. Prooxidant States and tumor promotion. Science (Washington DC), 227: 375-381, 1985.
7. Steele, V. E., Kelloff, G. J., Wilkinson, B. P., and Arnold, J. T. Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res., 50: 2068-2074, 1990.
8. O'Brien, P. Antioxidants and cancer: molecular mechanisms. In: D. Armstrong (ed.), Free Radicals in Diagnostic Medicine, pp. 215-239. New York: Plenum Press, 1994.
9. Flora, S. D., Astengo, M., Serra, D., and Bennicelli, C. Inhibition of urethane-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett., 32: 235-241, 1986.
10. Rostein, J. B., and Slaga, T. J. Anticarcinogenesis mechanisms, as evaluated in the multistage mouse skin model. Mutat. Res., 202: 421-427, 1988.
11. Pereira, M. A., and Khoury, M. D. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett., 61: 27-33, 1991.
12. Flora, S. D., Izzotti, A., D'Agostino, F., Balansky, R., and Cesarone, C. F. Chemopreventive properties of N-acetylcysteine and other thiols. In: L. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff (eds.), Cancer Chemoprevention, pp. 183-194. Boca Raton, FL: CRC Press, 1992.
13. Izzotti, A., D'Agostini, F., Bagnasco, M., Scatolini, L., Rovida, A., Balansky, R. M., Cesarone, C. F., and De Flora, S. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res., 54 (Suppl.): 1994s-1998s, 1994.
14. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
15. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
16. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W., Owen-Schaub, L. B., and Roth, J. A. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res., 54: 2287-2291, 1994.
17. Liu, T. J., El-Naggar, A. K., McDonnell, T. J., Steck, K. D., Wang, M., Taylor, D. L., and Clayman, G. L. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
18. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
19. Lowe, S. W., Bodis, S., McClatchey, A., Reminton, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 260: 807-810, 1994.
20. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J., and Kohn, K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57: 4285-4300, 1997.
21. Hainaut, P., and Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53: 4469-4473, 1993.
22. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Activation of the cryptic DNA binding function of mutant forms of p53. Nucleic Acids Res., 21: 3167-3174, 1993.
23. Rainwater, R., Parks, D., Anderson, M. E., Tegtmeyer, P., and Mann, K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol., 15: 3892-3903, 1995.
24. Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res., 48: 165-169, 1988.
25. Liu, M., and Pelling, J. C. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene, 10: 1955-1960, 1995.
26. Harney, D. M., and Levine, A. J. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev., 5: 2375-2385, 1991.
27. Ziegler, A., Jonason, A. S., Leffell, D. J., Simon, J. A., Sharma, H. W., Kimmelman, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
28. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
29. Graeber, T. G., Osmanian, C., Jacks, J., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
30. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Dyke, T. V. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
31. Morgenbesser, S. D., Williams, B. O., Jacks, T., and DePinho, R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (Lond.), 371: 72-74, 1994.
32. Brash, D. E. Cellular proofreading. Nat. Med., 2: 525-526, 1996.
33. Kastan, B. K., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
34. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
35. Liu, M., Dhanwada, K. R., Birt, D. F., Hecht, S., and Pelling, J. C. Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis (Lond.), 15: 1089-1092, 1994.
36. Maltzman, W., and Czyzyk, L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol., 4: 1689-1694, 1984.
37. Price, B. D., and Calderwood, S. K. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol ester. Oncogene, 8: 3055-3062, 1993.
38. Yunis, A. A., Lim, L. O., and Arimura, G. K. DNA damage induced by chloramphenicol and nitroso-chloramphenicol: protection by N-acetylcysteine. Respiration, 50 (Suppl.): 50-55, 1986.
39. Chan, J. Y. H., Stout, D. L., and Becker, F. F. Protective role of thiols in carcinogen-induced DNA damage in rat liver. Carcinogenesis (Lond.), 7: 1621-1624, 1986.
40. Solen, G. Radioprotective effect of N-acetylcysteine in vitro using the induction of DNA breaks as end-point. Int. J. Radiat. Biol., 64: 359-366, 1993.
41. Aruoma, O. I., Halliwell, B., Hoey, B. M., and Butler, J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Radic. Biol. Med., 6: 593-597, 1989.
42. Anderson, M. E., and Meister, A. Intracellular delivery of cysteine. Methods Enzymol., 143: 313-325, 1987.
43. Ceconi, C., Curello, S., Cargnoni, A., Boffa, G. M., and Ferrari, R. Antioxidant protection against damage during cardiac ischemia and reperfusion: effect of dimercaptopropanol. Cardioscience, 1: 191-198, 1990.
44. Packer, L., Witt, E. H., and Tritschler, H. J. α-Lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 19: 227-250, 1995.
45. Burgunder, J. M., Varriale, A., and Lauterburg, B. H. Effect of N-acetylcysteine on plasma cysteine and glutathione following paracetamol administration. Eur. J. Clin. Pharmacol., 36: 127-131, 1989.
46. Dolphin, D., Poulson, R., and Avramovic, O. (eds.) Glutathione: Chemical, Biochemical and Medical Aspects, Vol. 3. New York: John Wiley & Sons, 1989.
47. Lotem, J., Peled-Kamar, M., Groner, Y., and Sachs, L. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc. Natl. Acad. Sci. USA, 93: 9166-9171, 1996.
48. Irani, K., Xia, Y., Zweier, J. L., Scollot, S. J., Der, C. D., Fearon, E. R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P. J. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science (Washington DC), 275: 1649-1652, 1997.
49. Held, K. D., Sylvester, C. S., Hopcia, K. L., and Biaglow, J. E. Role of Fenton chemistry in thiol-induced toxicity and apoptosis. Radiat. Res., 145: 542-553, 1996.
50. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815-1823, 1994.
51. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defect in chromosome instability syndrome? Cell, 75; 765-778, 1993.
52. Khanna, K. K., and Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene, 8: 3307-3312, 1993.
53. Lipetz, P. D., Brash, D. E., Joseph, L. B., Jewett, H. D., Lisle, D. R., Lantry, L. E., Hart, R. W., and Stephens, R. E. Determination of DNA superhelicity and extremely low levels of DNA strand breaks in low numbers of nonradiolabeled cells by DNA-4′,6-diamidino-2-phenylindole fluorescence in nucleoid gradients. Anal. Biochem., 121: 339-348, 1982.
54. Larsen, K. H., Brash, D., Cleaver, J. E., Hart, R. W., Maher, V. M., Painter, R. B., and Sega, G. A. DNA repair assays as tests for environmental mutagens. Mutat. Res., 98: 287-318, 1982.
55. Renzing, J., Hansen, S., and Lane, D. P. Oxidative stress is involved in the UV activation of p53. J. Cell Sci., 109: 1105-1112, 1996.
56. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., and Deppert, W. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J., 14: 4442-4449, 1995.
57. Fu, L., Minden, M. D., and Benchimol, S. Translational regulation of human p53 gene expression. EMBO J., 15: 4392-4401, 1996.
58. Chu, E., and Allegra, C. J. The role of thymidylate synthase as an RNA-binding protein. Bioessays, 18: 191-198, 1996.
59. Jayaraman, L., Murthy, K. G. K., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11: 558-570, 1997.
60. Sun, Y., and Oberley, L. W. Redox regulation of transcriptional activators. Free Radic. Biol. Med., 21: 335-348, 1996.
61. Holdiness, M. R. Clinical pharmacokinetics of N-acetylcysteine. Clin. Pharmacokinet., 20: 123-134, 1991.
62. Weiner, B. (ed.) PDR Generics, 2nd ed. Montvale, NJ: Medical Economics Data, 1996.
63. WAF1/CIP1 via C/EBPβ. Nat. Med., 3: 1233-1241, 1997.
64. Kastan, M. B. To oxidize or not to oxidize? Nat. Med., 3: 1192-1193, 1997.
65. Ahmad, N., Feyes, D. K., Nieminen, A., Agarwal, R., and Mukhtar, H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst., 89: 1881-1886, 1997.